Triozone Pharmaceuticals Private Limited
About Triozone Pharmaceuticals Private Limited
Data last updated:
Triozone Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 02 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2016PTC290483. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jitendra Kumar and Sanchita Kumari.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at H. No. B – 286/D Ekta Vihar Jaitpur Extn. Badarpur, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2019, the company reported a revenue of ₹9.05 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1,356 (net margin 0.1%) and EBITDA of ₹31,780 (EBITDA margin 3.5%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. B – 286/D Ekta Vihar Jaitpur Extn. Badarpur, New Delhi, Delhi, India – 110044
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Triozone Pharmaceuticals Private Limited
The main business activity of Triozone Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Triozone Pharmaceuticals Private Limited FY 2019 filings available
Triozone Pharmaceuticals Private Limited reported revenue of ₹9.05 Lakh (up 7% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR) of Triozone Pharmaceuticals Private Limited
Revenue rose 7% in the latest year. EBITDA fell 22% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Triozone Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹9.05 Lakh | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹31,780 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,356 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Triozone Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.5% | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Triozone Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Triozone Pharmaceuticals Private Limited
Triozone Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Kumar | Director | 02 Feb 2016 | 10 Years 8 Months | Current |
| Sanchita Kumari | Additional Director | 23 Aug 2018 | 8 Years 1 Months | Current |
Peer Comparison of Triozone Pharmaceuticals Private Limited
Triozone Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Livway Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2025) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Adils Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | •••• | •••• | -15.0% | •••• | Lucknow, Uttar Pradesh, India |
| Hari Cure Pharmaceuticals Private Limited | ₹9.07 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Patna, Bihar, India |
| Elixir Pharmaceuticals Private Limited | ₹9.07 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Gurgaon, Haryana, India |
| Freefind Pharmaceuticals Private Limited | ₹9.07 Lakh (FY 2024) | •••• | •••• | •••• | Aligarh, Uttar Pradesh, India | |
| Triozone Pharmaceuticals Private Limited this company | ₹9.05 Lakh (FY 2019) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Bhartiya Pharmaceuticals India Private Limited | ₹9.05 Lakh (FY 2016) | •••• | •••• | 779.0% | •••• | Indore, Madhya Pradesh, India |
| Soxil Drugs and Pharmaceuticals Pvt Ltd | ₹9.03 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Ajmer, Rajasthan, India |
| Lifesource Pharmaceuticals Private Limited | ₹9.03 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Mumbai Dt 6 2, Maharashtra, India |
| Synbiodic Pharmaceuticals Private Limited | ₹9.01 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Myka Pharmaceuticals Private Limited | ₹9.01 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Triozone Pharmaceuticals by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Triozone Pharmaceuticals Private Limited
Triozone Pharmaceuticals Private Limited is audited by SHYAM LAL DADHICHI & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHYAM LAL DADHICHI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Triozone Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Triozone Pharmaceuticals Private Limited
Triozone Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Triozone Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Triozone Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Triozone Pharmaceuticals Private Limited
Triozone Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Arun Kumar ceased to be Director on 24 Aug 2018.
Credit Ratings, Litigation & Regulatory Alerts for Triozone Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Triozone Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Triozone Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Triozone Pharmaceuticals Private Limited
Triozone Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Triozone Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triozone Pharmaceuticals Private Limited
Triozone Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 02 February 2016 (10+ years old) and is registered under CIN U85100DL2016PTC290483.
Triozone Pharmaceuticals reported revenue of ₹9.05 Lakh for FY 2019 (up 7% YoY).
Triozone Pharmaceuticals has 2 current directors:
- Jitendra Kumar - Director
- Sanchita Kumari - Additional Director
Triozone Pharmaceuticals reported a net profit of ₹1,356 (net margin 0.1%) and EBITDA of ₹31,780 (EBITDA margin 3.5%) for FY 2019, as per its filed financial statements.
No. Triozone Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Triozone Pharmaceuticals is U85100DL2016PTC290483. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Triozone Pharmaceuticals was incorporated on 02 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Triozone Pharmaceuticals by revenue are Livway Pharmaceuticals Private Limited, Adils Pharmaceuticals Private Limited, Hari Cure Pharmaceuticals Private Limited, Elixir Pharmaceuticals Private Limited, Freefind Pharmaceuticals Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals).
Arun Kumar ceased to be Director on 24 Aug 2018. Sanchita Kumari was appointed as Additional Director on 23 Aug 2018. Jitendra Kumar was appointed as Director on 02 Feb 2016.
The registered office of Triozone Pharmaceuticals is at H. No. B – 286D Ekta Vihar Jaitpur Extn. Badarpur, New Delhi, Delhi, India – 110044.
Triozone Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.